HERE IS YOUR WARNING:
1. First royalties from TEMCELL product sales in Japan expected in Q1 CY 2016
2. In Q2 CY 2016 (which is just less than 2 weeks away) Teva and Mesoblast to provide updated timelines for completion of current REDUCED Phase 3 Trial of the Heart Failure Program, regulatory submissions, and overall program completion.
You read that right on #2 above - I said REDUCED.
Heed and don't get your hearts subjected to failure (CHF) when this stock explodes violently to the upside.
To those holding this down
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |